Company Search:
Advanced Search
Sponsored Links
Cannassure Therapeutics Ltd Company Snapshot
Cannassure Therapeutics Ltd operates within the Nonresidential building operators sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cannassure Therapeutics Ltd with three other companies in this sector in ISRAEL : Lodzia-Rotex Investment Ltd. (2011 sales of 24.92 million Israel Shekels [US$6.88 million] ), Vitala Capital Ltd (31.56 million Israel Shekels [US$8.71 million] ), and Liberty Properties Ltd. (30.21 million Israel Shekels [US$8.34 million] ).

Sales Analysis. During the year ended December of 2011, sales at Cannassure Therapeutics Ltd were 30.91 million Israel Shekels (US$8.53 million). This is a decrease of 1.7% versus 2010, when the company's sales were 31.44 million Israel Shekels.
  Stock Performance Chart for Cannassure Therapeutics Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/26/2020): .85
(Figures in Israel Shekels)
1 Week 27.9%   13 Weeks -14.6%  
4 Weeks -23.9%   52 Weeks -65.9%  
Cannassure Therapeutics Ltd Key Data:
  Ticker: CSURE Country: Israel
  Exchanges: TEL Major Industry: Real Estate
    Sub Industry: Nonresidential Building Operators
  2011 Sales 30,910,000
(Year Ending Jan 2012).
Employees: N/A
  Currency: Israel Shekels Market Cap: 47,469,337
  Fiscal Yr Ends: December Shares Outstanding: 55,649,867
  Share Type: Closely Held Shares: 39,145,082
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.